Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

3,010 public trials 644 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00006384

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

NCT01173445

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

Study of CP-461 in Patients With Advanced Renal Cell Cancer

NCT00036036

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UCLA Medical Center Los Angeles, California, United States

View Trial Details

Completed

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

NCT00622973

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: Inselspital Bern, Switzerland

View Trial Details

Completed

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

NCT00563147

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Stanford University Stanford, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

Nebraska Methodist Hospital Omaha, Nebraska, United States

View Trial Details

Completed

Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer

NCT01149174

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Dept. of Surgery, Tor Vergata University Rome, Italy

View Trial Details

Completed

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors

NCT00335491

Conditions: Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

NCT01442519

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Dept. of Surgery/Urology, Tor Vergata University Rome, RM, Italy

View Trial Details

Completed

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

NCT00277017

Conditions: Adenocarcinoma, Cancer, Carcinoma, +15 more
Locations: Lovelace Sandia Health Systems Dept of Hematology Albuquerque, New Mexico, United States

University of New Mexico Albuquerque, New Mexico, United States

New Mexico Cancer Care Associates Santa Fe, New Mexico, United States

View Trial Details

Completed

Phase 1 Study of OSI-930 in Cancer Patients

NCT00513851

Conditions: Adnexal Diseases, Advanced Solid Tumors, Bronchial Neoplasms, +49 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Cancer Research UK Professor of Medical Oncology Sutton, Surrey, United Kingdom

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions